Brayden Andersen-Masias, a recent WSU graduate, discovered his passion for international business during his study abroad experience in Portugal and ...
Shares of G1 Therapeutics plunged 46% after disappointing results from their Phase 3 trilaciclib combination trial for triple-negative breast cancer. ...